Purpose. This article reports on our experience treating vertebral fractures with percutaneous vertebroplasty. A clinical and imaging follow-up designed to identify the early (especially pulmonary embolism of bone cement) and late complications of the technique is proposed. Material and methods. On the basis of the current guidelines, 101 patients were selected: 64 osteoporotic and 37 neoplastic. A total of 173 vertebrae were treated. Procedures were performed with both computed tomography and fluoroscopic guidance. Residual pain was evaluated with a visual analogue scale score immediately after vertebroplasty and 1, 15, 30, 90, 180 and 270 days later. Spine and chest radiographs were obtained 24 h after vertebroplasty; spine radiography was repeated 30 days later. Results. Therapeutic success was obtained in 88% of osteoporotic patients and in 84% of neoplastic patients. Pulmonary cement emboli were identified in four patients, all of whom were asymptomatic. 
Introduction
Percutaneous vertebroplasty is an interventional procedure consisting of the injection, under fluoroscopic or computed tomographic (CT) guidance, of radiopaque bone cement into a diseased vertebral body to obtain pain relief and possible vertebral stabilisation. The treatment is indicated in subjects with osteoporotic vertebral collapse refractory to conservative management and in malignancies with severe pain related to destruction of the vertebral body (osteolytic metastasis and myeloma). It is currently performed with the aid of local anaesthesia only.
The aim of this paper is to present our experience with a series of patients treated at our institute and to describe patient selection criteria and the technique and its possible complications. With regard to complications, we propose adoption of a clinical and imaging follow-up protocol designed to identify both early (extravertebral cement leaks and pulmonary embolism) and late (collapse of adjacent vertebrae) complications.
Materials and methods

Patient selection criteria
In agreement with the guidelines of the Society of Interventional Radiology [1] and American College of Radiology [2] , the following conditions were considered indications for percutaneous vertebroplasty: 1. Painful osteoporotic fractures unresponsive to medical therapy 2. Painful fractures due to benign or malignant tumour, such as haemangioma, myeloma or metastatic disease Absolute contraindications were: 1. Stable asymptomatic fractures 2. Fractures responding to medical therapy 3. Prophylaxis in osteoporotic patients without evidence of acute fractures 4. Osteomyelitis of the target vertebra 5. Systemic infections 6. Traumatic fractures in nonosteoporotic vertebrae 7. Noncorrectable coagulopathy 8. Allergy to any materials used during the procedure Before the procedure, patients underwent clinical assessment to evaluate the site and intensity of pain, which had to be: severe, focal, located along the midline, exacerbated by palpation of the spinous process of the involved vertebra and by spinal flexion, and in the absence of radicular symptoms [3, 4] .
Preliminary two-view spinal radiographs were obtained to establish correspondence between pain site and fracture site. A magnetic resonance imaging (MRI) study was used
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Materiali e metodi
Criteri di selezione dei pazienti
In accordo con le linee guida della Society of Interventional Radiology [1] e dell'American College of Radiology [2] to distinguish among acute, subacute and chronic (where more than one vertebra was involved) fractures and to exclude other possible causes of pain, such as herniated disc or narrow vertebral canal. Further imaging with CT helped identify sites of potential cement leakage, as in posterior wall discontinuity [3, 5] .
Technical aspects
All patients received adequate information about the procedural aspects, benefits and risks of vertebroplasty and were asked to give written informed consent for the procedure. The procedures were performed without general anaesthesia, as we believe the patient should remain alert to be able to report the onset of pain or radicular symptoms. Local anaesthesia of the skin, subcutis and periosteum was achieved by administering 2-3 ml of 1% lidocaine for each vertebra being treated.
The bone cement used in all procedures was polymethylmethacrylate (PMMA) with the addition of barium sulphate, tungsten or zirconium dioxide. The injection was made via a 10-to 15-gauge steel needle cannulas 100-to 150-mm long. All procedures were done in the CT room, after positioning of a C-arm with digital fluoroscopy, under combined CT and fluoroscopic guidance.
Depending on the vertebra to be treated, one of three different percutaneous approaches were used: 1. Intercostovertebral: thoracic vertebrae 2. Transpedicular: lumbar vertebrae 3. Parapedicular: thoracic and lumbar vertebrae.
To help advance the needle into the vertebrae, we used a surgical hammer. Before injecting the cement, a biopsy was performed with a coaxial cutting needle to confirm the radiological diagnosis. The quantity of cement required was determined intraprocedurally by the operator on the basis of the residual size of the vertebra and the degree of filling obtained (mean injected volume per vertebra: 2 ml). A postprocedural CT scan, if necessary with three-dimensional reconstruction, allowed us to verify the correct distribution of cement within the vertebral body.
At the end of the procedure, patients remained in a supine position for at least 60 min after application of a flat dressing and ice over the needle entry point. Bed rest was recommended for at least 7-8 h. Where medical conditions permitted, patients were discharged the following day after a final assessment. [3, 5] . A total of 173 vertebral bodies were treated, distributed as follows: T5 (4), T6 (4), T7 (4), T8 (6), T9 (7), T10 (10), T11 (23), T12 (27) , L1 (36), L2 (20) , L3 (16), L4 (14) , L5 (2) . A total of 114 treatment sessions was performed; in nine patients, the procedure was repeated once or twice to treat new compression fractures at levels adjacent to treated vertebrae or to treat previously diagnosed compression fractures that had not been treated during the first session. In only one case was the procedure repeated on an vertebra treated in the first session: the patient was affected by a lung carcinoma metastasis involving L4 and had not experienced any improvement after the first vertebroplasty procedure. The second procedure was successful in relieving pain.
Aspetti tecnici
In 64 patients (120 treated vertebrae), indication for the procedure was an osteoporotic compression fracture. The mean age of these patients at the time of treatment was 75.6 (median 75.5) years. In 37 patients (53 treated vertebrae), the indication was neoplastic disease, namely, bone metastasis from bronchial carcinoma (7 cases), melanoma metastasis (5 cases), multiple myeloma (6 cases), non-Hodgkin's lymphoma of bone (5 cases), prostate carcinoma metastasis (3 cases), pancreatic exocrine carcinoma metastasis (1 case), gastric carcinoma metastasis (1 case), renal carcinoma metastasis (1 case), medullary thyroid carcinoma metastasis (1 case), breast carcinoma metastasis (3 cases), colon carcinoma metastasis (2 cases), vertebral angiosarcoma (1 case) and vertebral haemangioma (1 case). The mean age of these patients at the time of treatment was 63.7 (median 64) years.
In 49 patients, more than 1 vertebra was treated during the same session: 2 vertebrae in 36 patients, 3 in 11 and 4 in 2. Only 1 vertebra was treated in all the remaining sessions.
Assessment of results
The patient population was divided into two groups: patients with osteoporotic compression fractures and patients with neoplastic vertebral involvement. In consideration of the antalgic goal of percutaneous vertebroplasty, the fundamental parameter for assessing results in both groups was procedure effectiveness in terms of pain reduction or disappearance. Pain relief was assessed in all patients immediately after the procedure, at 24 h, at 15 days and at 1 month. At the end of the study, we were able to extend the followup period to 9 months for 65 patients (41 osteoporotic and 24 neoplastic), to 6 months for 14 (9 osteoporotic and 5 neoplastic) and to 3 months for 11 (7 osteoporotic and 4 neoplastic). Five patients were considered lost to followup: these were subjects receiving a different antalgic treatment simultaneously or subjects who died from intervening causes.
During the follow-up visits, patients were asked whether the pain had disappeared, was significantly or only moderately less, had remained unchanged or had worsened com- (6) , T9 (7), T10 (10) , T11 (23) , T12 (27) , L1 (36), L2 (20) , L3 (16) , L4 (14) , L5 (2) 
caso). L'età media di questi pazienti era, al momento del trattamento, di 63,7 anni (mediana 64 anni).
In 49 pazienti si è intervenuti su più metameri nella stessa sessione di trattamento: in 36 pazienti su 2 metameri, in pared with before vertebroplasty. Responses were scored from 1 to 5, where 1 indicates complete pain relief, 2 significant pain reduction, 3 moderate reduction, 4 no change and 5 worsening. This qualitative system for pain assessment is known as the visual analogue scale (VAS) score.
Data were analysed, and the success rate was calculated considering significant pain reduction or pain disappearance only (scores 1 and 2) as treatment success. The success rate was calculated on the number of treatment sessions. In addition, we calculated the incidence of intraprocedural cement leaks in the two groups of patients (osteoporotic and neoplastic); application of the χ 2 test to the results enabled us to analyse the relation between vertebral collapse aetiology and complication onset.
Starting with the 51st patient, we integrated clinical and imaging follow-up and studied all patients treated with radiography of the spine and chest: two-view spinal radiography and posteroanterior chest radiography were performed 24 h after the procedure; only the spinal study was repeated 30 days later. Spinal radiography at 24 h allows identification of the presence and location of possible bone-cement leaks; repetition of the examination after 30 days allows further assessment of cement stability and detection of possible secondary vertebral collapse in adjacent vertebrae. The chest radiograph at 24 h investigates the presence of PMMA pulmonary emboli, a rare but possible and potentially fatal event.
Results
In 88% and 84% of the procedures performed on osteoporotic and neoplastic patients, respectively, we achieved pain disappearance or significant reduction. The degree of pain relief achieved within the first 24 h remained constant for the entire duration of the follow-up in both patient groups. All patients who reported significant pain reduction or pain disappearance also experienced an improvement in mobility, unless this was affected by concurrent diseases, and were able to discontinue or reduce their use of analgesic agents. Twelve per cent of osteoporotic patients and 16% of neoplastic patients experienced only moderate symptom regression following the procedure, without improvement during the follow-up. No patient reported pain worsening following treatment.
Among patients with osteoporotic vertebral collapse, five developed pain at another level, leading to a second procedure, which was successful. Among patients with neoplastic vertebral collapse, three developed pain at another vertebral level and only one at the same level. The second procedure succeeded in relieving pain in these patients also.
Complications included small cement leaks in the paravertebral soft tissues (7 cases) (Fig. 1a) , intradiscal tissues (6 cases) (Fig. 1b) (Fig. 2) and paravertebral space (12 cases) (Fig. 3) . Fluoroscopic monitoring allowed the leaks to be detected during the injection phase, and immediate interruption of the injection limited their extent. After waiting a few seconds for the cement to block the leakage route, the injection was resumed. Clinically, all leaks were asymptomatic and did not require treatment. In no case did the cement leak affect the antalgic effect of the procedure, which was achieved in all cases.
Performance of the chest radiographs allowed us to identify four cases of PMMA pulmonary embolism (Figs. 4, 5) , none of which caused evident clinical symptoms. Approximately 20% of patients complained of mild pain arising at the treatment site immediately after the procedure, which was associated with haematoma in only one fifth of cases, and resolved rapidly and spontaneously in all cases. 
Discussion
Pain relief is the main goal of vertebroplasty. Although the injected cement does not restore the collapsed vertebra to its original volume, it modifies the vertebra's biomechanical characteristics, making it more resistant to compressive forces [6] [7] [8] and preventing further collapse. The resulting internal stabilisation is probably related to the mechanism responsible for complete or partial pain relief, as it reduces stimulation of the intraosseous and periosteal nerve endings by preventing micromotions of the fracture fragments [9, 10] . There is no evidence that pain relief depends on the quantity of cement injected. In treating osteoporotic vertebral collapse, timing of the procedure is crucial: the earlier the treatment, the greater the degree of pain relief. To this end, the use of imaging techquesti pazienti l'esecuzione di una nuova vertebroplastica ha avuto effetto antalgico.
Per quanto riguarda le complicanze, si sono osservate piccole fughe di cemento osseo nei tessuti molli paravertebrali (7 casi : Fig. 1a ), intradiscali (6 casi : Fig. 1b) 
Fig. 3a,b Fuga di cemento in una vena perivertebrale, immagine TC (a). Rilievo radioscopico durante la procedura (b).
a b niques able to date the time fracture onset and diagnose them is useful. In our study, we used MRI, exploiting the signal changes in trabecular bone to determine fracture age [11] . Acute and subacute fractures (less than 30 days old) are hypointense in T1-weighted sequences and hyperintense in T2-weighted and short tau inversion recovery (STIR) sequences. They may become isointense to the remaining healthy bone after gadolinium administration. Approxi- mately 1 month after a fracture, the majority of lesions becomes isointense to normal bone in both T1 and T2 sequences. When there is significant sclerosis, the fracture site appears hypointense in both T1 and T2. We used CT in all cases in which we felt it necessary to investigate posterior wall integrity (especially in neoplastic vertebral lesions): posterior wall discontinuity, above all when associated with a retropulsed bone fragment, increases the risk of leakage and subsequent compression of medullary structures in the spinal canal [12] .
With regard to intraprocedural imaging, we used combined fluoroscopic and CT guidance in 113 of 114 procedures. In one case only did we perform the procedure in the angiography suite using fluoroscopic C-arm guidance alone; this was due to a breakdown of the CT unit during the procedure. However, as the vertebra being treated was L4, the risk of paraplegia was nonexistent. In contrast, if the CT breakdown had occurred while treating a cervical or thoracic vertebra, we would not have considered it safe to proceed under fluoroscopic guidance alone, as the likelihood of permanent neurological complications would have been much higher. The literature shows that the only cases of permanent neurological complications occurred following procedures done without CT guidance. We therefore consider CT guidance advisable.
It should, however, be noted that most centres consider fluoroscopic guidance alone sufficient in most procedures and reserve CT for selected cases (cervical, high thoracic vertebrae or significant morphological or rotoscoliotic alterations of the skeletal segment being treated) [13] [14] [15] [16] . Fluoroscopic imaging remains irreplaceable for real-time monitoring of cement injection and distribution, allowing early detection of venous or paravertebral leaks requiring prompt interruption or suspension of the procedure. Conservative use of CT guidance limited to the cases described above, however, allows for lower doses and reduced procedure time and costs.
In our experience, out of 173 vertebrae treated, PMMA leaks occurred in 34 cases (Table 1) : 21 involved the paravertebral or epidural venous plexuses, creating a potential source of pulmonary emboli (which may, however, arise also in the absence of evident venous leaks), whereas in 13 cases, they involved the paravertebral or intersomatic soft tissue. By ordering the leaks observed according to the indication for vertebroplasty, we derived the following data: of 120 treated osteoporotic vertebrae, 23 cases developed leaks, equal to 19% of procedures; of these, 14 were venous (61%) and nine paravertebral or discal (39%). Of the 53 treated neoplastic vertebrae, 11 cases had leaks, equal to 21% of procedures, of which seven were venous (64%) and four paravertebral (36%).
The different incidence of cement leaks between osteoporotic patients and neoplastic patients, assessed with the χ 2 test, was not statistically significant (p>0.05). Consequently, the results of our study are in disagreement with those re- (p>0,05) . I risultati del nostro studio, quindi, sono in disaccordo con quelli di altri autori [12, 17] che associano alla natura tumorale di un crollo vertebrale sottoposto a vertebroplastica un aumentato rischio di fughe di cemento osseo, identificandone la causa nell'azione erosiva della neoplasia sulla limitante somatica.
Nonostante la ricca vascolarizzazione delle lesioni vertebrali neoplastiche, la natura dei crolli trattati è anche risultata statisticamente ininfluente nella determinazione di un leak venoso piuttosto che paravertebrale/discale non venoso.
I risultati del nostro studio dimostrano come la vertebroplastica percutanea sia efficace nel ridurre il dolore provocato da localizzazione neoplastica e da fratture osteoporotiche. I pazienti che abbiamo sottoposto alla procedura hanno riferito la scomparsa o la significativa riduzione del dolore immediatamente dopo la procedura e dopo 24 ore nel 88% dei casi quando colpiti da crollo osteoporotico, e nel 84% quando affetti da localizzazione neoplastica. Questi dati confermano quelli di altri autori riportanti alte percentuali di successo [4, 5, [18] [19] [20] [21] . In nessun soggetto si è avuto un peggioramento della sintomatologia, mentre i pazienti che non hanno tratto sollievo in maniera significativa dal trattamento erano affetti da fratture datate oltre sei mesi.
Il nostro follow-up clinico ha previsto controlli a 15 e 30 giorni, ripetuti a 3, 6 e 9 mesi. La riduzione del dolore ottenuta nella sede trattata immediatamente dopo la procedura si è mantenuta costante per la durata del follow-up in tutti i pazienti.
Nei pazienti neoplastici la ricomparsa del dolore nella sede trattata o in altri livelli è condizionata dalla progressione della malattia. La recidiva non controindica peraltro la ripetizione della procedura; nella nostra esperienza, 3 dei 37 pazienti neoplastici trattati sono stati sottoposti con successo ad una nuova procedura in seguito all'estensione della malattia ad altri metameri o a recidiva nello stesso già trattato. Recidive del dolore in pazienti colpiti da crolli osteoporotici possono essere causate dalla frattura di metameri adiacenti: alcuni studi ipotizzano una relazione tra le rinvigorite caratteristiche biomeccaniche della vertebra trattata ed il crollo dei metameri osteopenici adiacenti [22, 23] . La naturale tendenza della malattia osteoporotica a produrre fratture vertebrali multiple in metameri adiacenti ported by other authors [12, 17] who found vertebroplasty of neoplastic vertebral collapse to be associated with a higher risk of cement leakage, attributing the cause to end-plate erosion by the neoplasm.
Despite the rich vascularity of neoplastic vertebral lesions, the nature of the vertebral fractures treated was not found to correlate statistically with venous or nonvenous paravertebral/discal leaks.
The results of our study demonstrate the efficacy of percutaneous vertebroplasty in reducing pain induced by neoplastic lesions and osteoporotic compression fractures. Patients treated with the procedure reported complete or partial pain relief immediately after the procedure: 24 h after in 88% of cases of osteoporotic fractures and in 84% of cases of neoplastic fractures. These data confirm the high success rates reported by other authors [4, 5, [18] [19] [20] [21] . No patient reported pain worsening, whereas patients who failed to benefit significantly from the procedure were affected by fractures more than 6 months old.
Clinical follow-up involved visits at 15 and 30 days and at 3, 6 and 9 months. Pain reduction achieved immediately after the procedure remained constant throughout the follow-up in all patients.
In neoplastic patients, the reappearance of pain at the treated site or at other levels is dependent on disease progression. Recurrence is not, however, a contraindication for repeat procedures; in our experience, three out of 37 neoplastic patients were treated successfully with a second procedure following disease extension to other vertebrae or recurrence in a treated vertebra. Pain recurrence in patients with osteoporotic vertebral collapse may be related to the fracture of adjacent vertebrae: some studies have hypothesised a relationship between the strengthened biomechanics of a treated vertebra and the collapse of adjacent osteoporotentro un breve spazio di tempo osservata da altri autori [24] , associata alla perdita di sostanza ossea che si verifica nei corpi vertebrali adiacenti a quelli interessati da un crollo [25] ic vertebrae [22, 23] . The natural tendency of osteoporosis to produce multiple fractures in adjacent vertebrae within a short time interval noted by other authors [24] , associated with the bone loss occurring in vertebrae adjacent to those affected by collapse [25] , would tend to minimise the role of the treated vertebra in the pathogenesis of these new fractures. In our experience, eight out of 64 patients (12.5%) undergoing vertebroplasty for an osteoporotic fracture developed collapse of adjacent vertebrae within 30 days of the procedure. In all cases, treatment of the new fracture achieved pain relief.
The finding of three asymptomatic cases of pulmonary embolism due to PMMA, incidentally detected in patients who subsequently underwent routine preoperative chest Xray, combined with the growing number of similar cases reported in the literature [26] [27] [28] [29] [30] , prompted us to add radiological follow-up to the clinical follow-up already in place to ensure early detection of this type of complication. The marked opacity of bone cement, far greater than that of native bone, makes emboli identification easy. We thus decided to perform chest radiography 24 h after vertebroplasty on all treated patients; on this occasion, we also obtained a spinal radiograph, which was repeated at the follow-up visit at 30 days.
Our imaging follow-up has the following aims: -To detect PMMA pulmonary emboli early on -To check distribution of the injected cement -To search for secondary fractures involving other vertebral levels The sensitivity of the adopted protocol has been confirmed by one of the 51 patients included in the radiological follow-up who showed small high-density nodules (higher than the density of normal bone) in the left subclavian pulmonary region, referable to PMMA emboli. As with the patients with an incidental diagnosis, this patient was also asymptomatic. The frequent reports of frankly symptomatic cases, some with negative outcome, should not, however, lead us to underestimate this complication [27, 28] , above all in consideration of the high prevalence of chronic bronchopulmonary disease among our patients (on average aged over 70).
Our decision to use conventional radiology for the follow-up provides the protocol with the basic features of quality: effectiveness and efficiency. It is effective in terms of sensitivity and efficient in terms of cost, intended both as health care costs and patient radiation dose (Table 2) : performance of the three radiographic follow-up studies involves absorption of a mean dose of 2.02 mSv. A patient undergoing the same number of follow-up CT studies of the same body districts would absorb an 8.5-times higher dose.
Finally, none of the patients in our series experienced symptomatic complications other than temporary discomfort at the site of percutaneous access, which was reported by approximately 20% of patients and associated with haematoma in one fifth of cases.
Conclusions
Percutaneous vertebroplasty is a minimally invasive and effective procedure for relieving pain associated with osteoporotic or neoplastic vertebral collapse. Complications are rare and generally well tolerated; for this to remain true, it is important to select patients accurately, use combined fluoroscopic and CT guidance to check the needle route and monitor the injection in real time, and to carefully establish the volume of cement to be injected. Pain relief is independent of the amount of cement injected, which is, in contrast, directly related to the risk of leakage and complications.
Our radiological follow-up aims to detect cement pulmonary emboli early on, which is an uncommon but possible and potentially fatal complication. The method's high sensitivity and low cost in economic and biological terms justifies adoption of this follow-up protocol by the various centres offering vertebroplasty. Other follow-up imaging modalities have already been reported in the literature, but their use is aimed at studying the treated spine only [31] . [31] .
Conclusioni
